Mice vaccinated with enteropathogenic Escherichia coli ghosts show significant protection against lethal challenges

Letters in Applied Microbiology

Volumn 54, Issue 3, 2012, Pages 255-262

  Liu, J ^a,b   Wang, W D ^c   Liu, Y J ^d   Liu, S ^a   Zhou, B ^a,b   Zhu, L W ^a,b   Ji, X ^a,b   Sun, Y ^a,b   Feng, S Z ^a,b,c  

^a BEIJING INSTITUTE OF MICROBIOLOGY AND EPIDEMIOLOGY   (China)

^b The Key Laboratory of Jilin Province for Zoonosis Prevention and Control   (China)

^c JILIN UNIVERSITY   (China)

^d CHANGCHUN UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

Bacterial ghosts; Enteropathogenic Escherichia coli; Lysis gene E; Staphylococcal nuclease A

Indexed keywords

ESCHERICHIA COLI; GENES; IMMUNE SYSTEM; MAMMALS; PROTEINS; VACCINES;

BACTERIAL GHOSTS; DOWN-STREAM; ENTEROPATHOGENIC ESCHERICHIA COLI; IMMUNE RESPONSE; LYSE GENE E; LYSIS PROTEINS; RECOMBINANT PLASMID; STAPHYLOCOCCAL NUCLEASE; STAPHYLOCOCCAL NUCLEASE A; TEMPERATURE SENSITIVE;

IMMUNIZATION;

BACTERIAL VACCINE; BACTERIAL VECTOR; LYSIS PROTEIN E; STAPHYLOCOCCUS NUCLEASE A; UNCLASSIFIED DRUG;

ENZYME ACTIVITY; FECAL COLIFORM; GENE EXPRESSION; IMMUNE RESPONSE; LYSIS; PLASMID; RECOMBINATION; RODENT; SURVIVAL; VACCINATION; VIRULENCE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; CONTROLLED STUDY; ENTEROPATHOGENIC ESCHERICHIA COLI; ENTEROPATHOGENIC ESCHERICHIA COLI INFECTION; FEMALE; IMMUNE RESPONSE; MOUSE; NONHUMAN; RECOMBINANT PLASMID; SEROTYPE; VACCINATION; WILD TYPE;

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI; MUS;

EID: 84863061495     PISSN: 02668254     EISSN: 1472765X     Source Type: Journal    
DOI: 10.1111/j.1472-765X.2011.03202.x     Document Type: Article

References (29)

1. Agin, T.S., Zhu, C., Johnson, L.A., Thate, T.E., Yang, Z. and Boedeker, E.C. (2005) Protection against hemorrhagic colitis in an animal model by oral immunization with isogeneic rabbit enteropathogenic Escherichia coli attenuated by truncating intimin. Infect Immun 73, 6608-6619.
2. Chen, H.D. and Frankel, G. (2005) Enteropathogenic Escherichia coli: unravelling pathogenesis. FEMS Microbiol Rev 29, 83-98.
3. Drago-Serrano, M.E., Manjarréz Hernández, H.Á., Gavilanes Parra, S. and del Rosario Sainz Espuñes, T. (2004) Antibody response on mice immunized by mucosal routes with formalin-inactivated enteropathogenic Escherichia coli (EPEC) strains. Rev Latinoam Microbiol 46, 17-23.
4. Eko, F.O., Szostak, M.P., Wanner, G. and Lubitz, W. (1994) Production of Vibrio cholerae ghosts (VCG) by expression of a cloned phage lysis gene: potential for vaccine development. Vaccine 12, 1231-1237.
5. Eko, F.O., Mayr, U.B., Attridge, S.R. and Lubitz, W. (2000) Characterization and immunogenicity of Vibrio cholerae ghosts expressing toxin-coregulated pili. J Biotechnol 83, 115-123.
6. Haidinger, W., Mayr, U.B., Szostak, M.P., Resch, S. and Lubitz, W. (2003) Escherichia coli ghost production by expression of lysis gene E and staphylococcal nuclease. Appl Environ Microbiol 69, 6106-6113.
7. Iguchi, A., Thomson, N.R., Ogura, Y., Saunders, D., Ooka, T., Henderson, I.R., Harris, D., Asadulghani, M. et al. (2009) Complete genome sequence and comparative genome analysis of enteropathogenic Escherichia coli O127:H6 strain E2348/69. J Bacteriol 191, 347-354.
8. Jalava, K., Hensel, A., Szostak, M., Resch, S. and Lubitz, W. (2002) Bacterial ghosts as vaccine candidates for veterinary applications. J Control Release 85, 17-25.
9. Jalava, K., Eko, F.O., Riedmann, E. and Lubitz, W. (2003) Bacterial ghosts as carrier and targeting systems for mucosal antigen delivery. Expert Rev Vaccines 2, 45-51.
10. Keller, R., Hilton, T.D., Rios, H., Boedeker, E.C. and Kaper, J.B. (2010) Development of a live oral attaching and effacing Escherichia coli vaccine candidate using Vibrio cholerae CVD 103-HgR as antigen vector. Microb Pathog 48, 1-8.
11. Kwon, S.R., Kang, Y.J., Lee, D.J., Lee, E.H., Nam, Y.K., Kim, S.K. and Kim, K.H. (2009) Generation of Vibrio anguillarum ghost by coexpression of phiX 174 lysis E gene and staphylococcal nuclease A gene. Mol Biotechnol 42, 154-159.
12. Lee, D.J., Kwon, S.R., Zenke, K., Lee, E.H., Nam, Y.K., Kim, S.K. and Kim, K.H. (2008) Generation of safety enhanced Edwardsiella tarda ghost vaccine. Dis Aquat Organ 81, 249-254.
13. Luan, J., Zhuang, Z., Liu, Y., Yun, K., Chen, M. and Wang, P.G. (2010) Expression of EspA in Lactococcus lactis NZ9000 and the detection of its immune effect in vivo and in vitro. Immunopharmacol Immunotoxicol 32, 133-140.
14. Mayr, U.B., Haller, C., Haidinger, W., Atrasheuskaya, A., Bukin, E., Lubitz, W. and Ignatyev, G. (2005) Bacterial ghosts as an oral vaccine: a single dose of Escherichia coli O157:H7 bacterial ghosts protects mice against lethal challenge. Infect Immun 73, 4810-4817.
15. Nataro, J.P. and Kaper, J.B. (1998) Diarrheagenic Escherichia coli. Clin Microbiol Rev 11, 142-201.
16. Palm-Apergi, C. and Hallbrink, M. (2008) A new rapid cell-penetrating peptide based strategy to produce bacterial ghosts for plasmid delivery. J Control Release 132, 49-54.
17. Quintana Flores, V.M., Campos de Souza Fernandes, R.C., Sousa de Macedo, Z. and Medina-Acosta, E. (2002) Expression and purification of the recombinant enteropathogenic Escherichia coli vaccine candidates BfpA and EspB. Protein Expr Purif 25, 16-22.
18. Ra, C.H., Kim, Y.J., Park, S.J., Jeong, C.W., Nam, Y.K., Kim, K.H. and Kim, S.K. (2009) Evaluation of optimal culture conditions for recombinant ghost bacteria vaccine production with the antigen of Streptococcus iniae GAPDH. J Microbiol Biotechnol 19, 982-986.
19. Sambrook, J. and Russell, D.W. (2001) Molecular Cloning: A Laboratory Manual, 3rd edn. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press.
20. Schriefer, A., Maltez, J.R., Silva, N., Stoeckle, M.Y., Barral-Netto, M. and Riley, L.W. (1999) Expression of a pilin subunit BfpA of the bundle-forming pilus of enteropathogenic Escherichia coli in an aroA live salmonella vaccine strain. Vaccine 17, 770-778.
21. de Souza Campos Fernandes, R.C., Quintana Flores, V.M., Sousa de Macedo, Z. and Medina-Acosta, E. (2003) Coproantibodies to the enteropathogenic Escherichia coli vaccine candidates BfpA and EspB in breastfed and artificially fed children. Vaccine 21, 1725-1731.
22. Stakenborg, T., Vandekerchove, D., Marien, J., Laevens, H., Imberechts, H. and Peeters, J. (2006) Protection of rabbits against enteropathogenic Escherichia coli (EPEC) using an intimin null mutant. BMC Vet Res 23, 22-31.
23. Szostak, M.P., Hensel, A., Eko, F.O., Klein, R., Auer, T., Mader, H., Haslberger, A., Bunka, S. et al. (1996) Bacterial ghosts: non-living candidate vaccines. J Biotechnol 44, 161-170.
24. Torres, A.G., Zhou, X. and Kaper, J.B. (2005) Adherence of diarrheagenic Escherichia coli strains to epithelial cells. Infect Immun 73, 18-29.
25. Tu, F.P., Chu, W.H., Zhuang, X.Y. and Lu, C.P. (2010) Effect of oral immunization with Aeromonas hydrophila ghosts on protection against experimental fish infection. Lett Appl Microbiol 50, 13-17.
26. Wang, X. and Lu, C. (2009) Mice orally vaccinated with Edwardsiella tarda ghosts are significantly protected against infection. Vaccine 27, 1571-1578.
27. Witte, A. and Lubitz, W. (1989) Biochemical characterization of phi X174-protein-E-mediated lysis of Escherichia coli. Eur J Biochem 180, 393-398.
28. Witte, A., Wanner, G., Sulzner, M. and Lubitz, W. (1992) Dynamics of phiX174 protein E-mediated lysis of Escherichia coli. Arch Microbiol 157, 381-388.
29. Zhu, C., Feng, S.Z., Thate, T.E., Kaper, J.B. and Boedeker, E.C. (2006) Towards a vaccine for attaching/effacing Escherichia coli: a LEE encoded regulator (ler) mutant of rabbit enteropathogenic Escherichia coli is attenuated, immunogenic, and protects rabbits from lethal challenge with the wild-type virulent strain. Vaccine 24, 3845-3855.